Immunotherapy Combo Boosts Survival in Mouse Models of Mesothelioma, Study Finds
News
A combination of two immunotherapies — VIC-008 and Mozobil (plerixafor, or AMD3100) — suppresses mesothelioma growth and prolongs survival, suggesting a potential therapy for this type of cancer, a mouse ... Read more